Home / Systemic hormones / Tetracosactide
ATC H01AA02 · Acth
Tetracosactide shortage
As of 2 Nov 2026, Tetracosactide has a reported shortage in 2 of the 15 countries we track (Canada, Australia), covering 2 products from 1 company.
Countries2/15
Products2packs or presentations
Companies10 listed
Short since1 Feb 20197.8 years ago
Earliest return30 Nov 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustralia1 product short
Timeline
CanadaAustralia
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | SYNACTHEN DEPOT (1 mL ampoule) | MALLINCKRODT SPECIALTY PHARMACEUTICALS IRELAND LTD. | 28 Feb 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| AU | SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule | 1 Feb 2019 | 30 Nov 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.